13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q2 2016. See the latest, Q2 2026 →

Reported value

$292.47B

+0.8% on the quarter before

Positions

419

18 new · 29 sold out

Top 10

25.1%

of the value

Est. gain

+$7.29B

on stocks held all quarter

Est. return

+2.7%

on those stocks since Q1 2016

Filed

Aug 15, 2016

On SEC EDGAR ↗

Positions as of Jun 30, 2016, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

The 24 largest positions, 42% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.

Amgen Inc4.3%

Abbvie Inc3.2%

Verizon Communications Inc3.0%

Philip Morris International2.9%

Amazon2.7%Oracle2.3%Texas Instruments1.8%

Altria Group Inc1.8%

Union Pacific Corp1.6%

Netflix1.6%

Broadcom Ltd1.5%

Unitedhealth Group Inc1.4%

Canadian Natural Resources Ltd1.4%

Stryker Corp1.4%

American International Group Inc1.3%

Eog Resources Inc1.2%

AT&T1.2%

Coca-Cola Co1.2%

Intel1.2%

Medtronic Plc1.1%

Accenture Plc Cl A1.1%

Alexion Pharmaceuticals Inc1.0%

Alphabet1.0%Alibaba1.0%

Amgen Inc4.3%

Abbvie Inc3.2%

Verizon Communications Inc3.0%

Philip Morris International2.9%

Amazon2.7%Oracle2.3%Texas Instruments1.8%

Altria Group Inc1.8%

Union Pacific Corp1.6%

Netflix1.6%

Broadcom Ltd1.5%

Unitedhealth Group Inc1.4%

Canadian Natural Resources Ltd1.4%

Stryker Corp1.4%

American International Group Inc1.3%

Eog Resources Inc1.2%

AT&T1.2%

Coca-Cola Co1.2%

Intel1.2%

Medtronic Plc1.1%

Accenture Plc Cl A1.1%

Alexion Pharmaceuticals Inc1.0%

Alphabet1.0%Alibaba1.0%

Largest buys

Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Abbvie Inc~$4.73BAdded · 1.5% → 3.2%+76,593,054 shares
Chevron Corp~$1.09BAdded · 0.1% → 0.5%+10,417,906 shares
Qualcomm~$775.0MNew · 0.0% → 0.3%+14,466,460 shares
American International Group Inc~$707.0MAdded · 1.0% → 1.3%+13,367,970 shares
Freeport-McMoRan~$552.5MAdded · 0.2% → 0.4%+49,597,808 shares
IBM~$484.9MAdded · 0.2% → 0.4%+3,194,471 shares
Bank Of Montreal~$397.7MAdded · 0.1% → 0.3%+6,269,734 shares
Boeing Co~$349.4MAdded · 0.7% → 0.9%+2,690,120 shares
Teck Resources Ltd Cl B S/V~$329.3MAdded · 0.0% → 0.1%+25,014,000 shares
Itt Inc~$310.5MNew · 0.0% → 0.1%+9,710,010 shares

Largest sells

Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Monsanto Co~$1.72BCut · 0.9% → 0.5%−16,585,175 shares
St Jude Medical~$1.56BCut · 0.4% → 0.1%−19,989,217 shares
Baidu~$1.24BCut · 0.9% → 0.4%−7,512,298 shares
Amgen Inc~$973.8MCut · 4.6% → 4.3%−6,400,045 shares
Verizon Communications Inc~$680.1MCut · 3.1% → 3.0%−12,178,999 shares
General Dynamics Corp~$675.9MCut · 1.1% → 0.9%−4,853,992 shares
Albemarle Corp~$637.0MCut · 0.3% → 0.1%−8,032,341 shares
Cummins~$577.0MCut · 0.5% → 0.3%−5,131,297 shares
Centurylink Inc~$563.1MCut · 0.6% → 0.3%−19,411,685 shares
Automatic Data Processing~$528.1MCut · 0.2% → 0.0%−5,748,033 shares

Holdings

As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	Amgen IncCOMMON STOCK · shares −7.2% · price +1.5%	4.3%	4.6%	$12.61B	82.9M	−7.2%	$152.15	$149.93	+1.5%	+$184.0M
2	Abbvie IncCOMMON STOCK · shares +101% · price +8.2%	3.2%	1.5%	$9.44B	152.7M	+101%	$61.81	$57.12	+8.2%	+$357.1M
3	Verizon Communications IncCOMMON STOCK · shares −7.3% · price +3.3%	3.0%	3.1%	$8.70B	155.7M	−7.3%	$55.84	$54.08	+3.3%	+$274.1M
4	Philip Morris InternationalCOMMON STOCK · shares −0.5% · price +3.7%	2.9%	2.8%	$8.45B	83.0M	−0.5%	$101.72	$98.11	+3.7%	+$299.7M
5	AmazonCOMMON STOCK · shares −0.5% · price +20.5%	2.7%	2.2%	$7.80B	10.9M	−0.5%	$715.62	$593.64	+20.5%	+$1.33B
6	OracleCOMMON STOCK · shares −0.6% · price +0.0%	2.3%	2.3%	$6.68B	163.1M	−0.6%	$40.93	$40.91	+0.0%	+$3.3M
7	Texas InstrumentsCOMMON STOCK · shares −0.4% · price +9.1%	1.8%	1.7%	$5.22B	83.3M	−0.4%	$62.65	$57.42	+9.1%	+$435.5M
8	Altria Group IncCOMMON STOCK · shares −6.5% · price +10.1%	1.8%	1.7%	$5.22B	75.6M	−6.5%	$68.96	$62.66	+10.1%	+$476.5M
9	Union Pacific CorpCOMMON STOCK · shares −7.5% · price +9.7%	1.6%	1.6%	$4.65B	53.3M	−7.5%	$87.25	$79.55	+9.7%	+$410.6M
10	NetflixCOMMON STOCK · shares +1.5% · price −10.5%	1.6%	1.7%	$4.57B	50.0M	+1.5%	$91.48	$102.23	−10.5%	−$529.0M
11	Broadcom LtdCOMMON STOCK · shares −9.8% · price +0.6%	1.5%	1.7%	$4.41B	28.4M	−9.8%	$155.40	$154.50	+0.6%	+$25.5M
12	Unitedhealth Group IncCOMMON STOCK · shares +0.5% · price +9.5%	1.4%	1.3%	$4.11B	29.1M	+0.5%	$141.20	$128.90	+9.5%	+$356.3M
13	Canadian Natural Resources LtdCOMMON STOCK · shares +3.1% · price +14.1%	1.4%	1.2%	$4.05B	131.3M	+3.1%	$30.85	$27.05	+14.1%	+$484.8M
14	Stryker CorpCOMMON STOCK · shares +3.4% · price +11.7%	1.4%	1.2%	$3.95B	33.0M	+3.4%	$119.83	$107.29	+11.7%	+$399.8M
15	American International Group IncCOMMON STOCK · shares +24% · price −2.1%	1.3%	1.0%	$3.69B	69.7M	+24%	$52.89	$54.05	−2.1%	−$65.4M
16	Eog Resources IncCOMMON STOCK · shares +3.4% · price +14.9%	1.2%	1.0%	$3.60B	43.2M	+3.4%	$83.42	$72.58	+14.9%	+$452.3M
17	AT&TCOMMON STOCK · shares −11% · price +10.3%	1.2%	1.3%	$3.59B	83.2M	−11%	$43.21	$39.17	+10.3%	+$336.1M
18	Coca-Cola CoCOMMON STOCK · shares +4.1% · price −2.3%	1.2%	1.2%	$3.58B	79.1M	+4.1%	$45.33	$46.39	−2.3%	−$80.5M
19	IntelCOMMON STOCK · shares +4.8% · price +1.4%	1.2%	1.1%	$3.38B	103.1M	+4.8%	$32.80	$32.35	+1.4%	+$44.3M
20	Medtronic PlcCOMMON STOCK · shares +1.0% · price +15.7%	1.1%	0.96%	$3.25B	37.5M	+1.0%	$86.77	$75.00	+15.7%	+$437.2M
21	Accenture Plc Cl ACOMMON STOCK · shares −7.1% · price −1.8%	1.1%	1.2%	$3.23B	28.5M	−7.1%	$113.29	$115.40	−1.8%	−$60.2M
22	Alexion Pharmaceuticals IncCOMMON STOCK · shares −7.3% · price −16.1%	1.0%	1.3%	$2.99B	25.6M	−7.3%	$116.76	$139.22	−16.1%	−$574.7M
23	AlphabetCOMMON STOCK · shares −2.6% · price −7.1%	1.0%	1.1%	$2.93B	4.2M	−2.6%	$692.10	$744.95	−7.1%	−$224.1M
24	AlibabaCOMMON STOCK · shares +10% · price +0.6%	0.98%	0.89%	$2.87B	36.1M	+10%	$79.53	$79.03	+0.6%	+$16.4M
25	General Electric CoCOMMON STOCK · shares −5.0% · price −1.0%	0.95%	1.0%	$2.76B	87.8M	−5.0%	$31.48	$31.79	−1.0%	−$27.2M
	Total · 419 positions	100%		$292.47B						+$7.29B

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2016 to Q2 2016: 401 stocks held throughout, up $7.29B (+2.7%).

Amazon+$1.33B+21%
Halliburton Co+$536.3M+27%
Canadian Natural Resources Ltd+$484.8M+14%
Altria Group Inc+$476.5M+10%
Eog Resources Inc+$452.3M+15%
Skyworks Solutions−$286.3M−19%
Perrigo Co Plc−$301.4M−29%
Ubs Group Ag−$313.5M−20%
Netflix−$529.0M−11%
Alexion Pharmaceuticals Inc−$574.7M−16%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0

Q1 201642 quartersQ2 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q2 2026	Aug 12, 2026	$716.87B+11%	426	SEC ↗
Q1 2026	May 13, 2026	$644.56B+19%	459	SEC ↗
Q4 2025	Feb 11, 2026	$541.73B+2%	434	SEC ↗
Q3 2025	Nov 13, 2025	$532.97B+7%	433	SEC ↗
Q2 2025	Aug 13, 2025	$499.46B+9%	431	SEC ↗
Q1 2025	May 12, 2025	$459.90B−5%	456	SEC ↗
Q4 2024	Feb 13, 2025	$486.38B+1%	438	SEC ↗
Q3 2024	Nov 13, 2024	$481.14B+6%	415	SEC ↗
Q2 2024	Aug 13, 2024	$455.74B+3%	414	SEC ↗
Q1 2024	May 14, 2024	$441.98B+9%	410	SEC ↗
Q4 2023	Feb 13, 2024	$406.47B+12%	408	SEC ↗
Q3 2023	Nov 13, 2023	$363.16B−3%	411	SEC ↗
Q2 2023	Aug 11, 2023	$373.18B+7%	414	SEC ↗
Q1 2023	May 15, 2023	$350.40B+6%	425	SEC ↗
Q4 2022	Feb 14, 2023	$330.88B+9%	436	SEC ↗
Q3 2022	Nov 14, 2022	$304.37B−5%	429	SEC ↗
Q2 2022	Aug 15, 2022	$321.05B−21%	423	SEC ↗
Q1 2022	May 19, 2022 (amended)	$405.10B−11%	440	SEC ↗
Q4 2021	Feb 14, 2022	$452.67B+6%	440	SEC ↗
Q3 2021	Nov 15, 2021	$428.65B−0%	441	SEC ↗
Q2 2021	Aug 16, 2021	$429.52B+5%	436	SEC ↗
Q1 2021	May 14, 2021	$408.71B+6%	425	SEC ↗
Q4 2020	Feb 12, 2021	$385.30B+16%	404	SEC ↗
Q3 2020	Nov 13, 2020	$333.11B+5%	405	SEC ↗
Q2 2020	Aug 14, 2020	$316.13B+24%	399	SEC ↗
Q1 2020	May 15, 2020	$254.90B−24%	397	SEC ↗
Q4 2019	Feb 18, 2020	$333.48B+9%	405	SEC ↗
Q3 2019	Nov 14, 2019	$304.85B−3%	414	SEC ↗
Q2 2019	Aug 14, 2019	$314.99B−0%	401	SEC ↗
Q1 2019	May 15, 2019	$315.45B+10%	415	SEC ↗
Q4 2018	Feb 14, 2019	$287.02B−17%	417	SEC ↗
Q3 2018	Nov 14, 2018	$344.02B−6%	436	SEC ↗
Q2 2018	Aug 14, 2018	$366.12B+4%	440	SEC ↗
Q1 2018	May 15, 2018	$351.43B+3%	443	SEC ↗
Q4 2017	Feb 14, 2018	$340.76B+3%	432	SEC ↗
Q3 2017	Nov 14, 2017	$331.24B+4%	432	SEC ↗
Q2 2017	Aug 14, 2017	$319.49B+1%	431	SEC ↗
Q1 2017	May 15, 2017	$317.04B+3%	425	SEC ↗
Q4 2016	Feb 15, 2017	$308.47B+2%	427	SEC ↗
Q3 2016	Nov 14, 2016	$302.53B+3%	413	SEC ↗
Q2 2016	Aug 15, 2016	$292.47B+1%	419	SEC ↗
Q1 2016	May 16, 2016	$290.06B	430	SEC ↗